InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Toledano Miranda Jayne, Director. Insider active across 4 companies, notably Compass Therapeutics, Inc.. Aggregated, 17 filings have been published. Split: 6 buys · 0 sell. Total volume traded: €111k. History available since 27 December 2021. The latest transaction was disclosed on 14 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Toledano Miranda Jayne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
347,567 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-26-003508:0
72,993 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-26-003508:1
11,000 shares@ US$1.810216.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-004125:0
Canonical exit: 29 Mar 2026 (T+90)
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075266:0
136,842 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-002414:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066240:0
124,121 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-24-002391:0
9,728 shares0Common Stock, $0.0001 par valueSEC:0001104659-24-078970:0
23,952 shares@ US$0.7115.1% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-003971:0
Canonical exit: 21 Mar 2024 (T+90)
27,472 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-23-083831:0
30,000 shares@ US$1.0127.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-001348:0
Canonical exit: 3 Jul 2023 (T+90)
50,000 shares@ US$0.531725.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-003988:0
Canonical exit: 9 Feb 2023 (T+90)
14,245 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-22-082287:0
30,000 shares0COMMON STOCKSEC:0001104659-22-042282:0
6,800 shares@ US$2.789916.1% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000165:0
Canonical exit: 14 Apr 2022 (T+90)
1,819 shares@ US$5.49100.0% of flowCommon StockSEC:0001104659-22-000437:0
Canonical exit: 27 Mar 2022 (T+90)
1,791,549 sharesCommon Stock, $.0001 Par ValueSEC:0001686530-21-000006:0
17 of 17 declarations
About Toledano Miranda Jayne
Toledano Miranda Jayne is Administrateur and is involved with XNAS-listed companies, including Entera Bio Ltd. as Chief Executive Officer, and Journey Medical Corp, NEXGEL, INC., and Compass Therapeutics, Inc. as Director. Across 17 filings in total, the 17 filings available cover attribution transactions from 2021-06-29 to 2026-07-16, with 111471 EUR of buys and 0 EUR of sells.
